1. Home
  2. STOK vs WB Comparison

STOK vs WB Comparison

Compare STOK & WB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Stoke Therapeutics Inc.

STOK

Stoke Therapeutics Inc.

N/A

Current Price

$26.13

Market Cap

2.0B

Sector

Health Care

ML Signal

N/A

Logo Weibo Corporation

WB

Weibo Corporation

N/A

Current Price

$6.37

Market Cap

1.7B

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
STOK
WB
Founded
2014
2009
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Programming Data Processing
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
1.7B
IPO Year
2019
2014

Fundamental Metrics

Financial Performance
Metric
STOK
WB
Price
$26.13
$6.37
Analyst Decision
Strong Buy
Buy
Analyst Count
14
17
Target Price
★ $46.46
$8.24
AVG Volume (30 Days)
638.1K
★ 883.9K
Earning Date
11-03-2026
11-17-2026
Dividend Yield
N/A
★ 9.44%
EPS Growth
★ 92.73
N/A
EPS
N/A
★ N/A
Revenue
★ $184,420,000.00
N/A
Revenue This Year
N/A
$0.11
Revenue Next Year
$39.98
$0.78
P/E Ratio
★ N/A
$5.66
Revenue Growth
★ 404.50
N/A
52 Week Low
$20.32
$6.37
52 Week High
$40.22
$12.77

Technical Indicators

Market Signals
Indicator
STOK
WB
Relative Strength Index (RSI) 38.05 32.11
Support Level $25.21 N/A
Resistance Level $33.92 $6.79
Average True Range (ATR) 1.15 0.10
MACD -0.17 0.02
Stochastic Oscillator 36.31 25.00

Price Performance

Historical Comparison
STOK
WB

About STOK Stoke Therapeutics Inc.

Stoke Therapeutics Inc is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine. Its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antisense oligonucleotides (ASOs) to restore naturally-occurring protein levels selectively. Its first medicine in development, zorevunersen, has demonstrated the potential for disease modification in patients with Dravet syndrome. The company provides early programs focused on multiple targets, including haploinsufficiency diseases of the central nervous system and eye, to up-regulate the protein expression of the underlying disease gene in a mutation-agnostic manner.

About WB Weibo Corporation

Weibo Corp is a China-based company that operates a social media platform for people to create, discover and distribute content. The company currently operates and manages its business in two principal business lines globally - advertising and marketing services and value-added services. The Value-added Services mainly provide services such as membership services on social platforms, online games, live broadcasts, social e-commerce, and others. The company's main product is the social platform Weibo. It generates a substantial majority of its revenues from online advertising and marketing services.

Share on Social Networks: